Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: The aim of this trial is to identify the effect of ambulatory treatment in early COVID-19 disease with hydroxychloroquine on the rate of hospitalization or death in older patients above the age of 64. TRIAL DESIGN: Parallel, 2:1 randomization, double blind, placebo-controlled, multi-cent...

Descripción completa

Detalles Bibliográficos
Autores principales: Göpel, Siri, Bethge, Wolfgang, Martus, Peter, Kreth, Florian, Iftner, Thomas, Joos, Stefanie, Döbele, Stefanie, Mordmüller, Benjamin, Kremsner, Peter, Ettrich, Thomas, Seufferlein, Thomas, Bitzer, Michael, Malek, Nisar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348125/
https://www.ncbi.nlm.nih.gov/pubmed/32650818
http://dx.doi.org/10.1186/s13063-020-04556-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348125/
https://www.ncbi.nlm.nih.gov/pubmed/32650818
http://dx.doi.org/10.1186/s13063-020-04556-z

Ejemplares similares